DONGSUNG PHARMACEUTICAL CO.,LTD Logo

DONGSUNG PHARMACEUTICAL CO.,LTD

Develops and manufactures pharmaceuticals, cosmetics, and hair care products.

002210 | KO

Overview

Corporate Details

ISIN(s):
KR7002210003
LEI:
Country:
South Korea
Address:
서울특별시 도봉구 도봉로 683 (방학동) 동성빌딩, 서울특별시

Description

Dongsung Pharmaceutical Co., Ltd., established in 1957, develops, manufactures, and markets a diverse range of products across pharmaceuticals, cosmetics, and hair care. The company's pharmaceutical division produces over-the-counter (OTC) drugs and is expanding into health functional foods. Its portfolio also includes a variety of cosmetic products and is particularly known for its hair dyes. Dongsung Pharmaceutical focuses on developing nature-friendly products and is engaged in advanced research, including photodynamic therapy (PDT) for potential cancer treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-02-23 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 16.6 KB
2022-02-11 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.5 KB
2022-01-20 00:00
최대주주등소유주식변동신고서
Korean 31.5 KB
2021-12-23 00:00
자기주식취득결과보고서
Korean 22.9 KB
2021-12-22 00:00
최대주주등소유주식변동신고서
Korean 30.7 KB
2021-12-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2021-12-22 00:00
주식등의대량보유상황보고서(일반)
Korean 84.2 KB
2021-12-02 00:00
주요사항보고서(자기주식취득결정)
Korean 28.0 KB
2021-11-29 00:00
주식등의대량보유상황보고서(일반)
Korean 84.5 KB
2021-11-23 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 15.8 KB
2021-11-18 00:00
주식등의대량보유상황보고서(일반)
Korean 84.5 KB
2021-11-15 00:00
분기보고서 (2021.09)
Korean 959.6 KB
2021-10-07 00:00
자기주식취득결과보고서
Korean 23.7 KB
2021-08-23 00:00
유상증자또는주식관련사채등의발행결과(자율공시)
Korean 5.5 KB
2021-08-20 00:00
주요사항보고서(자기주식취득결정)
Korean 28.7 KB

Automate Your Workflow. Get a real-time feed of all DONGSUNG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGSUNG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGSUNG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.